Literature DB >> 18809775

The hazards of blood transfusion in historical perspective.

Harvey J Alter1, Harvey G Klein.   

Abstract

The beginning of the modern era of blood transfusion coincided with World War II and the resultant need for massive blood replacement. Soon thereafter, the hazards of transfusion, particularly hepatitis and hemolytic transfusion reactions, became increasingly evident. The past half century has seen the near eradication of transfusion-associated hepatitis as well as the emergence of multiple new pathogens, most notably HIV. Specific donor screening assays and other interventions have minimized, but not eliminated, infectious disease transmission. Other transfusion hazards persist, including human error resulting in the inadvertent transfusion of incompatible blood, acute and delayed transfusion reactions, transfusion-related acute lung injury (TRALI), transfusion-associated graft-versus-host disease (TA-GVHD), and transfusion-induced immunomodulation. These infectious and noninfectious hazards are reviewed briefly in the context of their historical evolution.

Entities:  

Mesh:

Year:  2008        PMID: 18809775      PMCID: PMC2962447          DOI: 10.1182/blood-2008-07-077370

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  83 in total

1.  Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions.

Authors:  A A Pineda; E C Vamvakas; L D Gorden; J L Winters; S B Moore
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

Review 2.  Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.

Authors:  P Brown
Journal:  Haemophilia       Date:  2007-12       Impact factor: 4.287

Review 3.  Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients.

Authors:  H Ohto; K C Anderson
Journal:  Transfus Med Rev       Date:  1996-01

4.  Pulmonary infiltrates associated with leukoagglutinin transfusion reactions.

Authors:  H N Ward
Journal:  Ann Intern Med       Date:  1970-11       Impact factor: 25.391

5.  Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes.

Authors:  H A Perkins; R Payne; J Ferguson; M Wood
Journal:  Vox Sang       Date:  1966 Sep-Oct       Impact factor: 2.144

6.  Isoimmunization after multiple transfusions.

Authors:  M M Lostumbo; P V Holland; P J Schmidt
Journal:  N Engl J Med       Date:  1966-07-21       Impact factor: 91.245

7.  Delayed hemolytic transfusion reaction presenting as sickle-cell crisis.

Authors:  W J Diamond; F L Brown; P Bitterman; H G Klein; R J Davey; R M Winslow
Journal:  Ann Intern Med       Date:  1980-08       Impact factor: 25.391

Review 8.  Pathogen inactivation: the definitive safeguard for the blood supply.

Authors:  Barbara J Bryant; Harvey G Klein
Journal:  Arch Pathol Lab Med       Date:  2007-05       Impact factor: 5.534

9.  Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease.

Authors:  W E Hathaway; J H Githens; W R Blackburn; V Fulginiti; C H Kempe
Journal:  N Engl J Med       Date:  1965-10-28       Impact factor: 91.245

10.  Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.

Authors:  S M Feinstone; K B Mihalik; T Kamimura; H J Alter; W T London; R H Purcell
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more
  67 in total

1.  Transfusion drains versus suction drains in total knee replacement: meta-analysis.

Authors:  Sheraz R Markar; Gareth G Jones; Alan Karthikesalingam; Nicholas Segaren; Rahul V Patel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-10       Impact factor: 4.342

Review 2.  Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.

Authors:  Ann Zeuner; Fabrizio Martelli; Stefania Vaglio; Giulia Federici; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

3.  Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial.

Authors:  Maria E Cabanillas; Hagop Kantarjian; Deborah A Thomas; Gloria N Mattiuzzi; Michael E Rytting; Eduardo Bruera; Lianchun Xiao; B Nebiyou Bekele; Maria C Foudray; Jorge E Cortes
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

4.  Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype.

Authors:  Francesca Masiello; Valentina Tirelli; Massimo Sanchez; Emile van den Akker; Girelli Gabriella; Maurizio Marconi; Maria Antonietta Villa; Paolo Rebulla; Ghazala Hashmi; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Transfusion       Date:  2013-09-04       Impact factor: 3.157

Review 5.  Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials.

Authors:  Zhi-Jun Li; Xin Fu; Dan Xing; Hua-Feng Zhang; Jia-Cheng Zang; Xin-Long Ma
Journal:  Eur Spine J       Date:  2013-05-09       Impact factor: 3.134

Review 6.  Supportive care in patients with acute leukaemia: historical perspectives.

Authors:  Giovanna Cannas; Xavier Thomas
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

7.  In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step.

Authors:  Mélanie Abonnenc; Giona Sonego; Julie Kaiser-Guignard; David Crettaz; Michel Prudent; Jean-Daniel Tissot; Niels Lion
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

8.  The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.

Authors:  Håkon Reikvam; Susanne Marschner; Torunn Oveland Apelseth; Ray Goodrich; Tor Hervig
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

9.  A new perspective on best transfusion practices.

Authors:  Aryeh Shander; Irwin Gross; Steven Hill; Mazyar Javidroozi; Sharon Sledge
Journal:  Blood Transfus       Date:  2013-01-22       Impact factor: 3.443

10.  Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.

Authors:  Linda M Griffith; Morton J Cowan; Luigi D Notarangelo; Jennifer M Puck; Rebecca H Buckley; Fabio Candotti; Mary Ellen Conley; Thomas A Fleisher; H Bobby Gaspar; Donald B Kohn; Hans D Ochs; Richard J O'Reilly; J Douglas Rizzo; Chaim M Roifman; Trudy N Small; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.